NO20085317L - Imidazoazepinonforbindelser - Google Patents

Imidazoazepinonforbindelser

Info

Publication number
NO20085317L
NO20085317L NO20085317A NO20085317A NO20085317L NO 20085317 L NO20085317 L NO 20085317L NO 20085317 A NO20085317 A NO 20085317A NO 20085317 A NO20085317 A NO 20085317A NO 20085317 L NO20085317 L NO 20085317L
Authority
NO
Norway
Prior art keywords
imidazoazepinonforbindelser
compounds
formula
methods
pharmaceutical compositions
Prior art date
Application number
NO20085317A
Other languages
English (en)
Inventor
Francis Fang
Shawn Schiller
Boris Seletsky
Mark Spyvee
Original Assignee
Eisai Res Inst Of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Res Inst Of Boston Inc filed Critical Eisai Res Inst Of Boston Inc
Publication of NO20085317L publication Critical patent/NO20085317L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Forbindelsen angår forbindelser av formel I: sammen med farmasøytiske sammensetninger inneholdende det samme og fremgangsmåter for bruk derav.
NO20085317A 2006-05-26 2008-12-19 Imidazoazepinonforbindelser NO20085317L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80890606P 2006-05-26 2006-05-26
US81561706P 2006-06-22 2006-06-22
PCT/US2007/012261 WO2007139813A1 (en) 2006-05-26 2007-05-23 Imidazoazephinone compounds

Publications (1)

Publication Number Publication Date
NO20085317L true NO20085317L (no) 2009-02-05

Family

ID=38608945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085317A NO20085317L (no) 2006-05-26 2008-12-19 Imidazoazepinonforbindelser

Country Status (15)

Country Link
US (1) US20090233906A1 (no)
EP (1) EP2021343A1 (no)
JP (1) JP2009538308A (no)
KR (1) KR20090029703A (no)
AU (1) AU2007267983B2 (no)
BR (1) BRPI0712166A2 (no)
CA (1) CA2651454A1 (no)
IL (1) IL195074A0 (no)
MX (1) MX2008015037A (no)
NO (1) NO20085317L (no)
RU (1) RU2008151761A (no)
SA (1) SA07280271B1 (no)
SG (1) SG158091A1 (no)
TW (1) TW200815017A (no)
WO (1) WO2007139813A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE474574T1 (de) * 2006-05-26 2010-08-15 Eisai R&D Man Co Ltd Imidazoazephinonverbindungen
US20090197867A1 (en) * 2007-11-15 2009-08-06 Mark Spyvee Enantiomerically enriched imidazoazepinone compounds
EP2217242A1 (en) * 2007-11-15 2010-08-18 Eisai R&D Management Co., Ltd. Methods of use
AU2007360955A1 (en) * 2007-11-15 2009-05-22 Eisai R & D Management Co., Ltd. Enantiomerically enriched imidazoazepinone compounds
EP2211616A4 (en) * 2007-11-26 2011-07-13 Eisai R&D Man Co Ltd PROCESS FOR PREPARING IMIDAZOAZEPINONE COMPOUNDS
CA2743584A1 (en) * 2008-11-23 2010-05-27 Pfizer Inc. Lactams as beta secretase inhibitors
GB0822011D0 (en) * 2008-12-02 2009-01-07 Queen Mary & Westfield College Treatment
WO2011011494A1 (en) * 2009-07-21 2011-01-27 Eisai R&D Management Co., Ltd. Imidazoazepinone compounds
RU2596403C2 (ru) 2010-06-09 2016-09-10 Куин Мэри Энд Вестфилд Колледж, Юниверсити Оф Лондон Антитело к аннексину а1
GB201121564D0 (en) 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
ATE474574T1 (de) * 2006-05-26 2010-08-15 Eisai R&D Man Co Ltd Imidazoazephinonverbindungen

Also Published As

Publication number Publication date
EP2021343A1 (en) 2009-02-11
US20090233906A1 (en) 2009-09-17
JP2009538308A (ja) 2009-11-05
MX2008015037A (es) 2008-12-10
WO2007139813A1 (en) 2007-12-06
TW200815017A (en) 2008-04-01
BRPI0712166A2 (pt) 2012-01-24
SG158091A1 (en) 2010-01-29
CA2651454A1 (en) 2007-12-06
AU2007267983A1 (en) 2007-12-06
IL195074A0 (en) 2009-08-03
KR20090029703A (ko) 2009-03-23
SA07280271B1 (ar) 2010-11-02
AU2007267983B2 (en) 2010-12-09
RU2008151761A (ru) 2010-07-10

Similar Documents

Publication Publication Date Title
NO20085317L (no) Imidazoazepinonforbindelser
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
EA201100037A1 (ru) Органические соединения
EA200970156A1 (ru) Пиридизиноновые производные
DK2074120T3 (da) Tropan-forbindelser
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
ATE549336T1 (de) Heteroarylverbindungen,zusammensetzungen daraus und ihre verwendung als proteinkinasehemmer
EA201170772A1 (ru) Органические соединения
CY1108445T1 (el) Νεα μεθοδος συνθεσης και νεα κρυσταλλικη μορφη της αγομελατινης καθως και φαρμακευτικες συνθεσεις που την περιεχουν
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
EA201071224A1 (ru) Ингибиторы limk2, композиции, содержащие их, и способы их применения
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
ATE474574T1 (de) Imidazoazephinonverbindungen
RS53002B (en) ANTI-CANCER UNIT AND PHARMACEUTICAL COPMOSITION CONTAINING IT
DE602007005387D1 (de) Ptors
MX2007007899A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application